CellaVision Q3 Sales Rise 13.6% to SEK 200M; EBITDA Margin 32%
CellaVision reported organic sales growth of 13.4%. EBITDA rose to SEK 64M, while pretax profit was SEK 51M, EPS SEK 1.68 and operating cash flow SEK 68M.
CellaVision reported Q3 2026 net sales of SEK 200M, up 13.6% YoY, with organic growth of 13.4%. EBITDA rose to SEK 64M (margin 32%), PBT to SEK 51M, EPS to SEK 1.68, and operating cash flow to SEK 68M.Material DetailsContext by AI AnalystResults reinforce a rebound toward the company’s 15% growth t…